Medicine and Dentistry
Bevacizumab
100%
Branch Retinal Vein Occlusion
100%
Transthyretin
100%
Protein
66%
Vasculotropin
22%
Retina
22%
Immunohistochemistry
22%
Mass Spectrum
11%
Upregulation
11%
Western Blot
11%
Synthetase
11%
Adenosine Triphosphate
11%
Choroid
11%
Intravitreal Administration
11%
Argon
11%
Tandem Mass Tag
11%
Recanalization
11%
Retinal Protein
11%
Fluorescein Angiography
11%
Pantothenate Kinase
11%
Salt Water
11%
Therapeutic Procedure
11%
Nursing and Health Professions
Bevacizumab
100%
Transthyretin
100%
Branch Retinal Vein Occlusion
100%
Protein
77%
Immunohistochemistry
22%
Vasculotropin
22%
Mass Spectrometry
11%
Western Blotting
11%
Adenosine Triphosphate
11%
Landrace
11%
Salt Water
11%
Intravitreal Drug Administration
11%
Fluorescence Angiography
11%
Synthetase
11%
Pantothenate Kinase
11%
Recanalization
11%
Neuroscience
Retinal Vein Occlusion
100%
Bevacizumab
100%
Transthyretin
100%
Protein
77%
Immunohistochemistry
22%
ATP Synthase
11%
Angiography
11%
Mass Spectrometry
11%
Fluorescein
11%
Pantothenate Kinase
11%